CalciMedica, Inc. Accounts Payable
CalciMedica, Inc. (CALC) had Accounts Payable of $2.07 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-11
- 2026-06-30: Accounts Payable, Current $2.07M.
- 2026-03-31: Accounts Payable, Current $1.68M.
- 2025-12-31: Accounts Payable, Current $1.16M.
- 2025-09-30: Accounts Payable, Current $1.13M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $2.07M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $1.68M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $1.16M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $1.13M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $1.91M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $2.02M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $2.00M 10-K · filed 2026-03-03 | |
| 2024-09-30 | $1.54M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $2.14M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $1.53M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $1.42M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $1.42M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.74M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $2.06M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $2.87M 10-K · filed 2024-03-28 | $1.72M 10-K · filed 2023-03-09 |
| 2022-09-30 | $498.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.01M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $541.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $527.00K 10-K · filed 2023-03-09 | |
| 2021-09-30 | $2.07M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $2.10M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $1.96M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $2.51M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $4.56M 10-Q · filed 2020-11-12 | |
| 2019-12-31 | $4.64M 10-K · filed 2021-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |